Sepracor says US board to hear inventorship claims on Pristiq
21 April 2009
Nancy Faigen
Sepracor will come face to face with
Wyeth next year over the issue of which company first filed patents in the US on a compound, racemic O-desmethylvenlafaxine succinate, used by Wyeth in its SNRI antidepressant Pristiq.
Wyeth refers to the compound as desvenlafaxine succinate. Pristiq extended-release...
Please Login to read the full article.
21 April 2009
Nancy Faigen
Wyeth refers to the compound as desvenlafaxine succinate. Pristiq extended-release...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Indian firms anticipate limited gains from generic Effexor XR launch
- Alkermes' PhII ALKS-5461: new mechanism, opiate receptor modulation, for refractory depression
- US Capitol Capsule: Could another biosimilars fight be a brewin'?
- US Capitol Capsule: Supreme Court takes another stab at refining US patent law
COMMENT
Other Informa Comment
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
